Pathstone Holdings’s Encompass Health EHC Stock Holding History

Pathstone Holdings’s Portfolio EHC Stock Details EHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.86M	Sell	29,610 -687	-2%	-$70.5K	0.01%	841
2025 Q4	$3.22M	Sell	30,297 -1,650	-5%	-$191K	0.01%	778
2025 Q3	$4.06M	Sell	31,947 -258	-0.8%	-$30.7K	0.02%	641
2025 Q2	$3.95M	Buy	32,205 +2,306	+8%	+$263K	0.02%	630
2025 Q1	$3.03M	Buy	29,899 +4,374	+17%	+$427K	0.01%	759
2024 Q4	$2.36M	Buy	25,525 +4,503	+21%	+$442K	0.01%	886
2024 Q3	$2.03M	Buy	21,022 +7,412	+54%	+$666K	0.01%	955
2024 Q2	$1.17M	Buy	13,610 +1,139	+9%	+$95.6K	0.01%	1234
2024 Q1	$1.03M	Buy	12,471 +6,009	+93%	+$440K	﹤0.01%	1263
2023 Q4	$432K	Buy	+6,462	New	+$419K	﹤0.01%	1599

Other funds holding EHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Pathstone Holdings's EHC Position: Q1 2026 in Review

Pathstone Holdings reduced its Encompass Health (EHC) stake by 2.3% in Q1 2026, selling an estimated $70.5K and leaving 29,610 shares worth $2.86M. The position accounts for 0.01% of the portfolio, ranked #841.

Pathstone Holdings first reported a position in EHC in Q4 2023 and has held it in 10 quarters since. The position peaked at $4.06M in Q3 2025. 577 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

Pathstone Holdings held 29,610 shares of Encompass Health worth $2.86M as of Q1 2026.
Pathstone Holdings sold 687 Encompass Health shares in Q1 2026, an estimated $70.5K.
Encompass Health made up 0.01% of Pathstone Holdings's portfolio in Q1 2026, its #841 holding.
Pathstone Holdings first reported a position in Encompass Health in Q4 2023 and has held it in 10 quarters since.
Pathstone Holdings's Encompass Health position peaked at $4.06M in Q3 2025.
577 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on Pathstone Holdings's 13F filing for Q1 2026, filed 11 May 2026.